MENU
LRMR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Larimar Therapeutics (LRMR) Earnings Date & Reports

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform... Show more

A.I. Advisor
published Earnings

LRMR is expected to report earnings to fall 22.98% to -34 cents per share on May 08

Larimar Therapeutics LRMR Stock Earnings Reports
Q1'25
Est.
$-0.35
Q4'24
Missed
by $0.14
Q3'24
Beat
by $0.13
Q2'24
Missed
by $0.03
Q1'24
Missed
by $0.03
The last earnings report on March 24 showed earnings per share of -44 cents, missing the estimate of -31 cents. With 927.92K shares outstanding, the current market capitalization sits at 136.38M.
View a ticker or compare two or three
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in the research and development of a therapeutic treatment for mitochondrial disorders and Friedreich's ataxia

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Three Bala Plaza East
Phone
+1 844 511-9056
Employees
42
Web
https://www.larimartx.com